SecBot SecBot
PRESS-RELEASE ·Filed Jul 9, 2026

SNN

Smith & Nephew UK Ltd
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight • Neutral

This is a clinical marketing press release, not a financial earnings report. No revenue, EPS, or guidance data was disclosed. Monitor upcoming quarterly filings for any impact on Advanced Wound Management segment sales. No immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

Smith+Nephew published a press release announcing a new German consensus-based clinical guidance for single-use negative pressure wound therapy (sNPWT) in closed surgical incisions, supported by the PICO 7 system. The release is a clinical marketing update, not a financial earnings report, no revenue, EPS, or guidance data were provided.

Key Facts

  • New German consensus-based clinical guidance for sNPWT in closed surgical incisions published in Die Chirurgie.
  • Guidance identifies at-risk patients (obesity, diabetes, smoking, prolonged surgery) for sNPWT use.
  • Smith+Nephew's PICO 7 sNPWT system is highlighted as the device supporting the guidance.
  • No financial data, revenue, EPS, or guidance was provided in this press release.

Financial Impact

No financial data provided; clinical guidance publication may support future PICO 7 adoption but no immediate revenue impact quantified.

Risk Factors

  • Clinical guidance does not guarantee increased adoption or revenue.
  • No financial data provided, cannot assess business performance from this release.

Market Snapshot

Exchange
OTC
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
50% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3324547

Track record

42 reports on SNN

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +8.02% at T+20 after the Jun 30, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 1/10 Entry $31.00 Now $30.97 −0.10% settles Nov 19
  2. Nov 4, 202612d ago 6-K Bearish 6/10 No price data
  3. Nov 4, 202612d ago 6-K Bearish 6/10 Entry $32.46 to $31.04 Now $30.97 +4.59% ▲ +4.37% +3.46% vs SPY
  4. Nov 2, 202614d ago 6-K Neutral 4/10 Entry $30.24 to $31.05 Now $30.97 +2.41% ▲ +2.68% +2.60% vs SPY
  5. Oct 22, 202625d ago 6-K Neutral 2/10 Entry $30.88 to $30.22 Now $30.97 +0.29% ▼ −2.14% −2.84% vs SPY
  6. Oct 8, 20265w ago 6-K Neutral 2/10 Entry $26.96 to $29.09 Now $30.97 +14.87% ▲ +7.90% +8.18% vs SPY
  7. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  8. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  9. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
  10. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
Showing 10 of 42

US Market Status

Market Closed · Opens Wed (10h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 9, 2026